High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects
Domains
Psychiatrics and mental healthOrigin | Publisher files allowed on an open archive |
---|